Table 1.
First author year | Protocol | Administrator | Patient population Number of participants (N) Validation instrument utilized |
Summary of protocol items | Sensitivity: Swallow safetya Dysphagiab |
Specificity: Swallow safetya Dysphagiab |
Volitional cough test included? |
---|---|---|---|---|---|---|---|
Martino et al. (2009) [53] | The toronto bedside swallowing screening test (TOR-BSST) | Nurse speech- language pathologist | Inpatient stroke: Acute*; Rehabilitation** (N = 311) VFSS |
Kidd 50 cc water swallow test; tongue movement; general dysphonia; voice quality before and after 50 mL liquid trial | Dysphagiab 91.3 % | Dysphagiab 66.7 % | No |
Mann (2002) [51] | Mann assessment of swallowing ability (MASA) | Speech-language pathologist | Acute stroke VFSS |
Ratings across the following items: Alertness; cooperation; auditory comprehension; respiration; respiratory rate during swallowing; dysphasia, dyspraxia; dysarthria; saliva; lip seal; tongue movement/strength/co-ordination; gag; palate; voluntary cough; reflexive cough during swallowing; voice; tracheotomy; pharyngeal response; diet recommendations; fluid recommendations | Aspirationa 93 % | Aspirationa 63 % | Yes |
Antonios et al. (2010) [52] | Modified mann assessment of swallowing ability (MMASA) | Physician Neurologist 1 Neurologist 2 |
Acute stroke* (N = 150) Comprehensive clinical assessment based on MASA |
Items rated? 1–12: alertness; cooperation; respiration; expressive dysphagia; auditory comprehension; dysarthria; saliva; tongue movement; tongue strength; gag; voluntary cough; palatal movements | Dysphagia (N 1) 92 % (N 1) 87 % |
Dysphagia (N 1) 86 % (N 1) 84 % |
Yes |
Trapl et al. (2007) [55] | Gugging swallowing screen (GUSS) | Speech-language pathologist (Gp 1) Nurse (Gp 2) |
Acute stroke* (N = 50) Group 1 n = 20 Group 2 n = 30 FEES |
Indirect swallow test: laryngeal elevation; saliva swallow; vigilance; voluntary cough; throat clearing Direct swallow test: six ½ tsp. puree, 3, 5, 10, 20, 50 cc thin liquid, small piece dry bread ×5 trials |
Aspirationa PAS = 4 and/or 5 Group 1: 100 % Group 2:100 % |
Aspirationa PAS = 4 and/or 5 Group 1: 50 % Group 2: 69 % |
Yes |
Edmiaston et al. (2010) [50] | Acute stroke dysphagia screen (ASDS) | Nurse | Acute stroke* (N = 300) MASA |
Glasgow Coma Scale; facial asymmetry; weakness of the face/tongue/palate; 3 oz. water swallow test | Aspirationa 95 % | Aspirationa 68 % | No |
Edmiaston et al. (2014) [49] | Barnes-jewish hospital Stroke dysphagia Screen (BJH-SDS) |
Nurse | Acute stroke* (N = 225) VFSS |
Glasgow coma scale; asymmetry; weakness; face/tongue/palate function; 3 oz. water swallow | Aspirationa 95 % Dysphagia 91 % |
Aspirationa 50 % Dysphagia 74 % |
No |
Hinds and wiles (1998) [54] | Timed swallow test | Physician | Acute stroke* (N = 93) |
Swallow questionnaire; 5–10 cc and 100–150 cc thin liquids serial timed swallowing trials | Not assessed | Not assessed | No |
Logemann et al. (1999) [58] | Northwestern dysphagia Patient check sheet |
Not specified | Heterogeneous*** (N = 200) VFSS |
Medical history; behavioral variables; gross motor function; oral motor exam; swallow trials of: 1 cc thin, 1 cc pudding, ¼ Lorna Doone cookie | Aspirationa & Dysphagia Reported for 28 individual items |
Aspirationa & Dysphagia Reported for 28 individual items |
Yes |
Suiter and Leder (2008) [59] | 3-oz. Water Swallow test (WST) | Speech-Language Pathologist | Heterogeneous*** (N = 3000) FEES |
90 cc sequential liquid swallow trial. Fail: cannot complete, wet vocal quality, cough/throat clear within one minute after completion |
Aspirationa 96.5 % | Aspirationa 48.7 % | No |
Suiter et al. (2014) [56] | Yale swallow protocol | Speech-language Pathologist | Heterogeneous*** (N = 25) VFSS |
Cognitive screen; brief oral mechanism examination and liquid swallow trial of 90 cc of water. Patient instructed to drink continuously without stopping | Aspirationa 100 % | Aspirationa 64 % | No |
Clave et al. (2008) [57] | Volume-viscosity Swallow test (V-VST) | Speech swallow therapist | Heterogeneous*** Control N = 12 Patients N = 85 VFSS |
Swallow trials including 5, 10, and 20 cc of nectar thick liquid, thin liquid, and pudding. | Penetration 83.7 % Aspiration 100 % |
Penetration 64.7 % Aspiration 28.8 % |
No |
cc cubic centimeter; FEES fiberoptic endoscopic evaluation of swallowing; mL milliliter; oz.ounce; VFSS: videofluoroscopic swallow study
Acute stroke defined as patients admitted to hospital immediately following a stroke;
Rehabilitation stroke is defined as Patients in a sub-acute rehabilitation facility following stroke;
Heterogeneous population by author includes the following: Logemann [58]: single stroke, multiple strokes, head and neck cancer, spinal cord injury, other; Suiter [59]: cardiothoracic surgery, esophageal surgery, head and neck surgery, neurosurgery, medical, pulmonary, cancer, other, left stroke, right stroke, brainstem stroke, Parkinson’s disease, dementia, other neurological; Suiter [56]: esophageal surgery, head and neck cancer, neurosurgery, medical, neurological (stroke, multiple sclerosis, traumatic brain injury); Clave [57]: cerebrovascular disease, chronic pneumopathy, diabetes, geriatric diseases, neurodegenerative diseases (amyotrophic lateral sclerosis, multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, Duchenne muscular dystrophy, and other), Zenker’s diverticulum, cricopharyngeal bar, post surgical, and tracheotomy
Swallow Safety: Sensitivity and specify outcome measures in reference to swallow safety status and the presence of penetration or aspiration
Dysphagia: Outcome measures in reference to the presence or absence of general swallowing impairment (dysphagia)